Incidence, mechanism and prognostic value of activated AKT in pancreas cancer. - Wikidata - wikimedia - TriplyDB

Incidence, mechanism and prognostic value of activated AKT in pancreas cancer.

Incidence, mechanism and prognostic value of activated AKT in pancreas cancer.

http://www.wikidata.org/entity/Q36648105

about

Genetic determinants and potential therapeutic targets for pancreatic adenocarcinoma Ack1 mediated AKT/PKB tyrosine 176 phosphorylation regulates its activation Shepherding AKT and androgen receptor by Ack1 tyrosine kinase Molecular targets for the treatment of pancreatic cancer: Clinical and experimental studies Genomic alterations in pancreatic cancer and their relevance to therapy Targeting p110gamma in gastrointestinal cancers: attack on multiple fronts Hepatocyte nuclear factor 1A (HNF1A) as a possible tumor suppressor in pancreatic cancer Ack1 tyrosine kinase activation correlates with pancreatic cancer progression Molecular targets of isothiocyanates in cancer: recent advances Pancreatic tumor suppression by benzyl isothiocyanate is associated with inhibition of PI3K/AKT/FOXO pathway.PAK4 interacts with p85 alpha: implications for pancreatic cancer cell migration Oral mTOR inhibitor everolimus in patients with gemcitabine-refractory metastatic pancreatic cancer.Evolution of systemic therapy for advanced pancreatic cancer.Epidermal growth factor induces HCCR expression via PI3K/Akt/mTOR signaling in PANC-1 pancreatic cancer cells.Sulforaphane synergizes with quercetin to inhibit self-renewal capacity of pancreatic cancer stem cells.Phosphorylation status of Akt and caspase-9 in gastric and colorectal carcinomas.Pancreatic cancer: molecular pathogenesis and new therapeutic targets.The prolyl peptidases PRCP/PREP regulate IRS-1 stability critical for rapamycin-induced feedback activation of PI3K and AKT Resveratrol inhibits growth of orthotopic pancreatic tumors through activation of FOXO transcription factors.Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer.EGCG enhances the therapeutic potential of gemcitabine and CP690550 by inhibiting STAT3 signaling pathway in human pancreatic cancer.Akt activation is a common event in pediatric malignant gliomas and a potential adverse prognostic marker: a report from the Children's Oncology Group.Grape proanthocyanidin inhibit pancreatic cancer cell growth in vitro and in vivo through induction of apoptosis and by targeting the PI3K/Akt pathway.Capecitabine: an evidence-based review of its effectiveness in the treatment of carcinoma of the pancreas Pancreatic cell plasticity and cancer initiation induced by oncogenic Kras is completely dependent on wild-type PI 3-kinase p110α Biology and management of pancreatic cancer.Genetic and molecular alterations in pancreatic cancer: implications for personalized medicine.Activation of EGFR-PI3K-AKT signaling is required for Mycoplasma hyorhinis-promoted gastric cancer cell migration.Evaluation of survival in patients after pancreatic head resection for ductal adenocarcinoma.Molecular characteristics of pancreatic ductal adenocarcinoma RGS16, a novel p53 and pRb cross-talk candidate inhibits migration and invasion of pancreatic cancer cells.Overcoming drug resistance in pancreatic cancer.Activation of the PIK3CA/AKT pathway suppresses senescence induced by an activated RAS oncogene to promote tumorigenesis.Nanoparticle formulation of ormeloxifene for pancreatic cancer ACK1/TNK2 tyrosine kinase: molecular signaling and evolving role in cancers.Overexpression/amplification of HER-2/neu is uncommon in hepatocellular carcinoma.Prognostic value of activated Akt expression in oral squamous cell carcinoma.Role of erlotinib in the management of pancreatic cancer.Cotargeting MAPK and PI3K signaling with concurrent radiotherapy as a strategy for the treatment of pancreatic cancer Current knowledge on pancreatic cancer.

P2860

Q21129230-B995C87D-B29C-4BBD-8ABD-17F767084E1B Q21142629-2D9667A8-8F4F-43F4-AA0E-7F650ECBB80C Q24308859-B10C3C83-A201-4C68-AA24-A0AD481B3361 Q26774636-FD3F407C-CA76-4175-818D-8E702962958B Q26781443-414473B1-E981-4AD2-BE44-8FED31286CB9 Q26823575-21036D46-94A7-494B-BD04-56AD6A6A20CA Q28259270-AF37E303-CB06-4998-8B0F-F791B75991BB Q28259414-B3281AFA-475B-4E60-8E8C-3BA747F966A3 Q28307527-55CB4046-93E6-4453-943B-04BB9CF08DAF Q30499567-0B415234-0CBC-4992-8702-DCBDA1B9C483 Q30838867-57A91EC8-BB37-4A1B-A0C3-80AB2B252B20 Q33382236-34B8E7F7-583A-4A30-A57E-079F1CFA009A Q33557413-73DFB80D-06C1-4637-9480-4D77EFD3BF21 Q33566269-81654C13-56E8-405B-B303-7CEAAAAC95AB Q33842071-38C9E571-4518-4AB6-AF65-9D28984C0917 Q33898789-70FB8A27-A973-4EED-94E2-A18DE5C3C669 Q33899954-68C92C00-61A5-49E8-BA6F-D8B943DE6947 Q33985384-E978E52E-7BA7-4C65-BB15-836C2C050490 Q34042949-932196A5-7FC3-4553-968A-A2ED997A1F9E Q34043823-EC83E032-D5F7-4309-BD25-88458F072977 Q34163334-F798849E-5CFB-4964-BF1D-4CA855AD507E Q34196216-8CE531C5-BF78-4920-8406-05C97DA494B5 Q34384695-80AD420A-342A-4D3B-9EA7-E00C732B37CD Q34449812-177863C2-26C6-41A0-92AA-0598AEEAA14E Q34590266-D7828096-E619-4405-9B7D-218BD0019BD6 Q34649019-441E025E-F95B-4A67-B382-83EA59190473 Q34657038-D5446E56-ECD5-4986-AF4B-E577F0A344CA Q34671334-353B7A5C-CC64-4CCB-B8C0-E73151EF525E Q34680864-A7F509E8-BEC9-4CB3-AA06-6A12CDD90031 Q34745252-7B9E6F67-3846-4CFE-B20D-255ED34C7634 Q34786650-EE204716-128A-44A0-8EF2-98DAB1D54DD0 Q35036615-E29CDBD3-7484-46D3-BE52-C7CB540FD3A3 Q35132940-7A337760-1481-45EE-8255-FFD1DC86BDF1 Q35517037-72FB9C40-CDBC-4FAF-8171-30E1FCF2ADC5 Q35542942-C96338AD-EC82-4864-8BFD-AD25F2AC0F97 Q35588545-73DA4EAE-8F21-40B4-858B-7A0385F06C32 Q35588865-E40A8BE4-F5E3-4C47-AF28-FF65E146DF4E Q35919264-015285DF-F518-46CA-8841-3014A3CD03D5 Q35951620-CD3295D4-D244-43D8-A16B-1FB53C8FCDEA Q35971808-1FC24E6C-ACE0-4976-9C5E-E0B81AF444C4

P2860

Incidence, mechanism and prognostic value of activated AKT in pancreas cancer.

http://www.wikidata.org/entity/Q36648105

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Incidence, mechanism and prognostic value of activated AKT in pancreas cancer.

@ast

Incidence, mechanism and prognostic value of activated AKT in pancreas cancer.

@en

type

label

Incidence, mechanism and prognostic value of activated AKT in pancreas cancer.

@ast

Incidence, mechanism and prognostic value of activated AKT in pancreas cancer.

@en

prefLabel

Incidence, mechanism and prognostic value of activated AKT in pancreas cancer.

@ast

Incidence, mechanism and prognostic value of activated AKT in pancreas cancer.

@en

P1433

Q36648105-EC246D56-8373-4BF2-A74E-815B892041A2

P1476

Q36648105-E054CCEE-53B3-4583-8E70-02D48F7F0FA8

P2093

Q36648105-449B16F7-83F6-4457-AE4D-B1BA22182FF6

Q36648105-BE7296E8-49E6-4C11-AF23-2D11033F37E0

Q36648105-C7F41173-2EB5-48F9-94B8-24FA3BD4514E

Q36648105-DDE9B08A-A00B-47BC-9933-4B58CC7CA051

Q36648105-FEFFDED6-A91D-4AC7-A161-E81BEF2E8497

P2860

Q36648105-065665C5-0D0D-41EC-A295-937DF5203F71

Q36648105-0B9385A1-5C46-4A80-B01D-FD3CCD73508C

Q36648105-0C0A9A9D-06CF-4F19-BCE2-4A93B5CE2336

Q36648105-10F088B2-65CA-44F3-A3A8-074F8BF33429

Q36648105-1402A120-484A-4733-BCED-A3E41D445651

Q36648105-1945F7E7-4A43-4C26-8AB6-D832A6C73231

Q36648105-1D975755-D679-4F2D-A4EA-A65E6A9F34CE

Q36648105-42EA9D07-AD87-4D25-AC72-C2817D42A628

Q36648105-509E75B7-6A44-4AE1-A25F-6D1FE19567FD

Q36648105-51D66B48-F115-4079-9E7E-3637447AAC5A

P2888

Q36648105-B2DF8C04-1E39-4543-8CE6-791DCEF0D792

P304

Q36648105-A4C3C9AB-00B7-472D-A2DB-21168749BCE6

P31

Q36648105-9AE67378-166E-4053-9091-CA7389D8B4D0

P356

Q36648105-86F4B137-4D7F-47F4-A5F0-B0D227BC2912

P407

Q36648105-55438643-F83B-417B-9909-0BE7A6E03141

P433

Q36648105-42F298FE-26B0-4E90-8D65-DEF81BC230AD

P478

Q36648105-943E740B-C1A9-423E-9146-C21DBA515FC8

P577

Q36648105-18445B06-ECA6-485F-A2C7-3F98063450FB

P5875

Q36648105-4CED2650-D4B1-4FDB-BFBA-167CEDE7F221

P698

Q36648105-588E93E3-1AA9-42E0-81C4-2A6C6C510941

P921

Q36648105-720042B4-7820-427E-AE9E-616BDD4EA770

P932

Q36648105-B1937AAB-9373-4306-8AC9-B72DE4F14D1E

P356

P1433

British Journal of Cancer

P1476

Incidence, mechanism and prognostic value of activated AKT in pancreas cancer.

@en

P2093

B N Fahy

http://www.w3.org/2001/XMLSchema#string

L Beckett

http://www.w3.org/2001/XMLSchema#string

M G Schlieman

http://www.w3.org/2001/XMLSchema#string

R J Bold

http://www.w3.org/2001/XMLSchema#string

R Ramsamooj

http://www.w3.org/2001/XMLSchema#string

P2860

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

Prognosis of human pancreatic adenocarcinoma: review of clinical and histopathological variables and possible uses of new molecular methods.

Present and future treatment of pancreatic cancer.

Pancreatic cancer biology and genetics.

Activation of the PI3K/Akt pathway and chemotherapeutic resistance.

Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patients

AKT inhibition is associated with chemosensitisation in the pancreatic cancer cell line MIA-PaCa-2

Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer.

Transforming growth factor-beta 2 is a transcriptional target for Akt/protein kinase B via forkhead transcription factor.

Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction.

P2888

P304

2110-2115

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6601396

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

89

http://www.w3.org/2001/XMLSchema#string

P577

2003-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8984012

http://www.w3.org/2001/XMLSchema#string

P698

14647146

http://www.w3.org/2001/XMLSchema#string

P921

Aizkuņģa dziedzeris

P932

2376856

http://www.w3.org/2001/XMLSchema#string